glp-1 news today 2025 november You've probably seen the about the recent TrumpRx announcement — here's what it actually means if you're on or considering GLP-1s 👇 The deal between TrumpRx, Eli Lilly, and Novo Nordisk Seven reforms to increase access

Foundational GLP-1 Physiology Review (PubMed, 2007) GLP-1 as Incretin, Enterogastrone, and Appetite Regulator Establishing the Full Physiological Profile A comprehensive review of GLP-1 physiology published on PubMed confirmed that GLP-1 is a 30-amino acid peptide hormone produced in intestinal L-cells by differential processing of proglucagon, released in response to meal intake

Boehringer Ingelheims Cyltezo (adalimumab-adbm) was the first interchangeable adalimumab biosimilar, approved in 2021

Adequate protein intake is essential for preserving muscle mass, supporting metabolic function, maintaining energy levels, and promoting long-term weight-loss successparticularly for women navigating hormonal transitions such as perimenopause, discussed further in Perimenopause Nutrition Foundations

The first generic semaglutide will not arrive until patents expire around 20322033, but increased competition from new oral medications like orforglipron (Foundayo) is putting downward pressure on pricing across the board

Hormone therapy is a tool

5 Must-Know Myths About Weight-Loss Medications